SARS-CoV-2 and Immunity: Natural Infection Compared with Vaccination.
COVID-19 vaccines
T-cell polyfunctionality
polychromatic flow cytometry
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Aug 2022
11 Aug 2022
Historique:
received:
27
07
2022
revised:
09
08
2022
accepted:
10
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
30
8
2022
Statut:
epublish
Résumé
Recently, the protective and/or pathological role of virus-specific T cells in SARS-CoV-2 infection has been the focus of many studies. We investigated the anti-spike IgG levels and SARS-CoV-2-specific T cells in 125 donors (90 vaccinated with four different vaccine platforms, 16 individuals with a previous natural infection, and 19 not vaccinated donors who did not report previous SARS-CoV-2 infections). Our data show that anti-spike IgG titers were similar between naturally infected subjects and those vaccinated with adenoviral vector vaccines. Of note, all immunized donors produced memory CD4
Identifiants
pubmed: 36012246
pii: ijms23168982
doi: 10.3390/ijms23168982
pmc: PMC9409314
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Viral Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Med (N Y). 2021 Jun 11;2(6):682-688.e4
pubmed: 33851143
Vaccines (Basel). 2022 Mar 26;10(4):
pubmed: 35455263
Semin Immunol. 2021 Jun;55:101508
pubmed: 34728121
Nat Commun. 2021 Jun 30;12(1):4043
pubmed: 34193870
Nat Rev Immunol. 2021 Jun;21(6):395-404
pubmed: 33927374
Theranostics. 2021 Jan 1;11(4):1690-1702
pubmed: 33408775
N Engl J Med. 2021 Dec 16;385(25):2348-2360
pubmed: 34587382
Int J Environ Res Public Health. 2021 Dec 03;18(23):
pubmed: 34886515
N Engl J Med. 2022 Jun 2;386(22):2084-2096
pubmed: 35507508
Vaccines (Basel). 2021 Oct 12;9(10):
pubmed: 34696272
J Clin Invest. 2020 Sep 1;130(9):4694-4703
pubmed: 32463803
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Nat Immunol. 2020 Nov;21(11):1336-1345
pubmed: 32887977
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222
Nat Med. 2021 Nov;27(11):2032-2040
pubmed: 34588689
NPJ Vaccines. 2021 Aug 16;6(1):104
pubmed: 34400651
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Nat Med. 2021 Jun;27(6):1055-1061
pubmed: 33875890
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Biomedicines. 2021 Aug 18;9(8):
pubmed: 34440239
Vaccines (Basel). 2021 Apr 01;9(4):
pubmed: 33915829
Indian J Microbiol. 2020 Dec;60(4):420-429
pubmed: 33012868
Lancet. 2021 May 1;397(10285):1646-1657
pubmed: 33901420
Lancet Microbe. 2022 May;3(5):e348-e356
pubmed: 35345417
Science. 2022 Jan 07;375(6576):43-50
pubmed: 34812653
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
Nature. 2022 Mar;603(7901):488-492
pubmed: 35102311
Cell. 2022 Jul 7;185(14):2434-2451.e17
pubmed: 35764089
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Nat Rev Mol Cell Biol. 2022 Jan;23(1):3-20
pubmed: 34611326
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Int J Surg. 2022 Aug;104:106727
pubmed: 35753656
Neurobiol Aging. 2012 Nov;33(11):2599-611
pubmed: 22330173
Cell Host Microbe. 2021 Nov 10;29(11):1611-1619.e5
pubmed: 34688376